维力医疗收盘上涨1.03%，滚动市盈率18.44倍，总市值43.23亿元

Core Viewpoint - Weili Medical's stock closed at 14.76 yuan, with a rolling PE ratio of 18.44 times, significantly lower than the industry average of 55.91 times, indicating potential undervaluation in the medical device sector [1][2] Company Summary - Weili Medical specializes in the research, production, and sales of medical catheters in fields such as anesthesia, urology, respiration, and hemodialysis [1] - The company's main products include tracheal intubation, laryngeal masks, bronchial intubation, visual bronchial intubation, tracheostomy tubes, anesthesia masks, artificial noses, anesthesia breathing circuits, electronic analgesia pumps, urinary catheters, drainage bags, and various other specialized medical devices [1] Financial Performance - For the first half of 2025, Weili Medical reported revenue of 745 million yuan, a year-on-year increase of 10.19% [1] - The net profit for the same period was 121 million yuan, reflecting a year-on-year growth of 14.17% [1] - The company's gross profit margin stood at 45.04% [1] Institutional Holdings - As of the 2025 semi-annual report, 16 institutions held shares in Weili Medical, including 8 funds, 6 other institutions, 1 social security fund, and 1 insurance company, with a total holding of 161.66 million shares valued at 2.056 billion yuan [1]